Myocarditis is characterized by inflammation of the myocardium and is known for its heterogeneous clinical presentation and outcome [1–5]. The course of the disease varies, ranging from full recovery to a spectrum of serious cardiac complications, including dilated cardiomyopathy, heart failure, recurrent myocarditis, ventricular arrhythmias, and sudden cardiac death [6–10]. This variability underscores the urgent need for effective risk stratification tools to guide clinical decision-making. Id…